Article Information
PubMed
Print ISSN
Online ISSN
History
- Received October 12, 2016
- Accepted November 23, 2016
- Published online January 24, 2017.
Article Versions
- Earlier version (November 28, 2016 - 10:35).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Laura Nogués,
- Clara Reglero,
- Verónica Rivas,
- María Neves,
- Petronila Penela, and
- Federico Mayor Jr.
- Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
- Address correspondence to:
Federico Mayor, Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid, Spain. E-mail: fmayor{at}cbm.csic.es
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- Introduction
- Canonical and Noncanonical Roles of GRK2
- GRK2 Regulates Cell Proliferation and Survival Cascades
- GRK2 Modulates Immune and Epithelial Cell Motility
- GRK2 Modulates Key Cell Metabolism Networks
- GRK2 Roles in Tumoral Angiogenesis and in the Proinflammatory Tumor Microenvironment
- Changes in GRK2 Expression/Activity in Specific Tumors and Functional Impact
- Concluding Remarks
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement